Exchange: OTC·Updated 02:57 PM EDT

HLUBF H. Lundbeck AS - Ordinary Shares - Class A

$5.54
$0.1132
(2.08%)
Today
EarningsNov 11
Mkt Cap$5.5B
Vol481.00

About HLUBF

H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. It operates through the following geographical segments: Europe, United States, and International Operations. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.
50

Neutral Sentiment

How do you feel about HLUBF?

Advertisement|Remove ads.